Department of Reproductive Biology, National Institute for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo 157-8535, Japan.
Genes Cells. 2011 Jan;16(1):1-11. doi: 10.1111/j.1365-2443.2010.01459.x. Epub 2010 Dec 13.
Stem cells have a capability to self-renew and differentiate into multiple types of cells; specific markers are available to identify particular stem cells for developmental biology research. In this study, we aimed to define the status of somatic stem cells and the pluripotency of human embryonic stem (hES) and induced pluripotent stem (iPS) cells using a novel molecular methodology, lectin microarray analysis. Our lectin microarray analysis successfully categorized murine somatic stem cells into the appropriate groups of differentiation potency. We then classified hES and iPS cells by the same approach. Undifferentiated hES cells were clearly distinguished from differentiated hES cells after embryoid formation. The pair-wise comparison means based on 'false discovery rate' revealed that three lectins -Euonymus europaeus lectin (EEL), Maackia amurensis lectin (MAL) and Phaseolus vulgaris leucoagglutinin [PHA(L)]- generated maximal values to define undifferentiated and differentiated hES cells. Furthermore, to define a pluripotent stem cell state, we generated a discriminant for the undifferentiated state with pluripotency. The discriminant function based on lectin reactivities was highly accurate for judgment of stem cell pluripotency. These results suggest that glycomic analysis of stem cells leads to a novel comprehensive approach for quality control in cell-based therapy and regenerative medicine.
干细胞具有自我更新和分化为多种类型细胞的能力;特定的标记物可用于鉴定特定的干细胞,以进行发育生物学研究。在这项研究中,我们旨在使用新型分子方法——凝集素微阵列分析来定义体细胞干细胞的状态和人类胚胎干细胞(hES)和诱导多能干细胞(iPS)的多能性。我们的凝集素微阵列分析成功地将鼠体细胞干细胞分类为适当的分化潜能组。然后,我们采用相同的方法对 hES 和 iPS 细胞进行分类。未分化的 hES 细胞在形成类胚体后明显区别于分化的 hES 细胞。基于“错误发现率”的两两比较均值表明,三种凝集素——欧洲卫矛凝集素(EEL)、美洲商陆凝集素(MAL)和菜豆白细胞凝集素[PHA(L)]——生成了最大的值,以定义未分化和分化的 hES 细胞。此外,为了定义多能干细胞状态,我们生成了一个用于未分化状态的多能性判别函数。基于凝集素反应性的判别函数对于判断干细胞多能性非常准确。这些结果表明,对干细胞的糖组学分析为基于细胞的治疗和再生医学中的质量控制提供了一种新的综合方法。